PABLO
AGUIAR FERNANDEZ
Profesor contratado doutor
Ludwig Maximilian University of Munich
Múnich, AlemaniaPublicacións en colaboración con investigadores/as de Ludwig Maximilian University of Munich (2)
2024
-
Perspectives of the European Association of Nuclear Medicine on the role of artificial intelligence (AI) in molecular brain imaging
European Journal of Nuclear Medicine and Molecular Imaging
2023
-
FDA approval of lecanemab: the real start of widespread amyloid PET use? — the EANM Neuroimaging Committee perspective
European Journal of Nuclear Medicine and Molecular Imaging